Medication info

NutriFlex Lipid Special Injection

Prescription medication정맥
Ingredient · strength
Glucose Monohydrate›158.4g / 1000mLMonobasic Sodium Phosphate Dihydrate›2496mg / 1000mLZinc Acetate Hydrate›7.024mg / 1000mLSoybean Oil›20g / 1000mLTriglycerides Medium-Chain›20g / 1000mLIsoleucine›3.288g / 1000mLL-Leucine›4.384g / 1000mLLysine Hydrochloride›3.984g / 1000mLMethionine›2.736g / 1000mLPhenylalanine›4.92g / 1000mLThreonine›2.544g / 1000mLTryptophan›0.8g / 1000mLValine›3.608g / 1000mLArginine›3.784g / 1000mLL-Histidine Hydrochloride Monohydrate›2.368g / 1000mLAlanine›6.792g / 1000mLAspartic Acid›2.104g / 1000mLGlutamic Acid›4.912g / 1000mLGlycine›2.312g / 1000mLProline›4.76g / 1000mLSerine›4.2g / 1000mLSodium Hydroxide›1.171g / 1000mLSodium Chloride›0.378g / 1000mLSodium Acetate Hydrate›0.25g / 1000mLPotassium Acetate›3.689g / 1000mLMagnesium Acetate Tetrahydrate›0.91g / 1000mLCalcium Chloride Hydrate›0.623g / 1000mL
Manufacturer / importer
비브라운코리아(주)
Appearance
Acolorless, transparent liquid emulsion contained in a bag made of polyamide and polypropylene materials, divided into three compartments - two on the top and one at the bottom.
Packaging
Bag - 1250 milliliters / Bag
Approval status
Active

MFDS item code 200511365 · Notified 2005.11.04 · Insurance code 667400570

Summary

Main use
Nutritional and fluid supply treatment for patients unable to take oral or gastrointestinal nutrition.
Who receives it
Adults
Adult administration
Administer via central venous route. The infusion rate should be determined considering the total volume to be administered, the characteristics of the final mixed solution, daily dosage, and infusion time. Typically, the infusion rate is gradually increased during the first 30 minutes of administration until an appropriate dosage is reached. The maximum infusion rate should not exceed 1.7 mL/kg/hour. The dosage is determined based on the patient's condition and caloric expenditure, not to exceed 40 kcal/kg per day.

Ingredients

Importer
비브라운코리아(주)

Efficacy & effects

Nutritional and fluid supply treatment for patients unable to take oral or gastrointestinal nutrition.

View approved original text

This medication is used to supply fluids, electrolytes, amino acids, and calories to patients who cannot take food orally or where nutrition intake through the gastrointestinal tract is insufficient, thereby replenishing essential nutrition.

How it is given

Adult administration

Administer via central venous route. The infusion rate should be determined considering the total volume to be administered, the characteristics of the final mixed solution, daily dosage, and infusion time. Typically, the infusion rate is gradually increased during the first 30 minutes of administration until an appropriate dosage is reached. The maximum infusion rate should not exceed 1.7 mL/kg/hour. The dosage is determined based on the patient's condition and caloric expenditure, not to exceed 40 kcal/kg per day.

Precautions

This medication must be used strictly according to a doctor's instructions, and the administration should be stopped immediately if allergic reactions such as fever, chills, rash, or breathing difficulties occur. When used with intravenous calcium preparations, mixing should be avoided, and particular caution is needed when used with ceftriaxone due to potential precipitation. It is safer not to administer to premature or low-birth-weight infants, as their lipid metabolism capacity is low and poses a risk. It should not be administered to patients with specific conditions such as premature infants, newborns, those allergic to eggs or soybean oil, severe renal failure, or liver disease. Administer carefully to patients with renal failure, pancreatitis, liver dysfunction, heart failure, and diabetes while frequently monitoring blood lipid levels and other test values. Excessive or rapid administration may cause side effects, so caution is necessary, and if symptoms such as fever, breathing difficulties, or vomiting occur, administration should stop immediately. During prolonged administration, regular tests of liver function and blood tests should be performed to detect adverse reactions early. Before administration, ensure that the patient's hydration, electrolyte, and acid-base balance is normal, and if lipid metabolism abnormalities are suspected, check blood lipid levels before administration. This medication may raise blood glucose levels, so blood glucose should be monitored periodically, and insulin dosages adjusted accordingly if needed. If anaphylaxis or hypersensitivity reactions are suspected, administration should be stopped immediately, and appropriate measures taken. Maintain aseptic conditions during administration to prevent infection, use immediately after opening and do not store any leftover medication. Be aware of potential drug interactions when used in combination with other medications, and consult a professional beforehand. Particularly, care should be taken not to administer it concurrently with blood. The safety for pregnant or breastfeeding women has not been established, so the benefits and risks should be carefully considered before administration. When testing after administration, the drug's lipid component may affect the test results, so blood sampling should ideally be done 5-6 hours after administration. Signs of excess dosage may include acidosis, hypervolemia, hyperglycemia, dehydration, pulmonary edema, so inform medical personnel immediately and seek appropriate treatment. Store the medication in undamaged packaging, protect it from light, and store it at a temperature between 15-25 degrees Celsius, avoiding freezing.

Side effects and when to seek care immediately

Serious side effects

Anaphylactic reactions (fever, rash, breathing difficulties), severe allergic reactions, hepatomegaly and jaundice, thrombophlebitis, fat overload syndrome (including coma), respiratory distress, fat accumulation in the pulmonary vasculature, hyperlipidemia, electrolyte imbalance, pulmonary edema, severe edema, headache (severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis symptoms are not specified, but headache has been reported), increased blood pressure or

Mild side effects

  • Fever
  • sweating
  • tremors
  • headache
  • vomiting
  • shivering
  • loss of appetite
  • nausea
  • pain in the back
  • bone
Show 22 more
  • chest
  • or waist area
  • increased or decreased blood pressure
  • hypersensitivity symptoms
  • skin flushing
  • cyanosis
  • fever
  • abdominal pain
  • fatigue
  • anemia
  • leukopenia
  • thrombocytopenia
  • abnormal blood coagulation
  • abnormal blood symptoms
  • symptoms of vascular irritation
  • phlebitis
  • thrombophlebitis
  • hyperglycemia
  • hyperlipidemia
  • hepatomegaly
  • splenomegaly
  • abnormal liver function.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air or light, important to keep away from direct sunlight, and at a cool temperature between 15 and 25 degrees Celsius.

Appearance and packaging

Appearance

Acolorless, transparent liquid emulsion contained in a bag made of polyamide and polypropylene materials, divided into three compartments - two on the top and one at the bottom.

Package unit

Bag - 1250 milliliters / Bag

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.